{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:15:39Z","timestamp":1794665739978,"version":"4.9.1"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Tianjin Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23JCYBJC00980"],"award-info":[{"award-number":["23JCYBJC00980"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104585"],"award-info":[{"award-number":["82104585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31800722"],"award-info":[{"award-number":["31800722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.metabol.2024.155953","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:15:05Z","timestamp":1718464505000},"page":"155953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"157","author":[{"given":"Yutong","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.155953_bb0010","first-page":"50","article-title":"MASLD co-aggregates with HCC in families-names change, fa(c)ts remain","volume":"9","author":"Lonardo","year":"2023","journal-title":"Hepatoma Res"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0015","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0025","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1053\/j.gastro.2022.01.058","article-title":"Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective","volume":"162","author":"Bauer","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.155953_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174319","article-title":"Ferroptosis as a new therapeutic opportunity for nonviral liver disease","volume":"908","author":"Jia","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.metabol.2024.155953_bb0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"issue":"7784","key":"10.1016\/j.metabol.2024.155953_bb0045","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.metabol.2024.155953_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2147\/JIR.S385977","article-title":"The emerging role of ferroptosis in various chronic liver diseases: opportunity or challenge","volume":"16","author":"Zhu","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.metabol.2024.155953_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.20517\/2394-5079.2022.92","article-title":"Challenges and barriers in hepatocellular carcinoma (HCC) surveillance for patients with non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Wegermann","year":"2023","journal-title":"Hepatoma Res"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000362888","article-title":"Physiology of iron metabolism","volume":"41","author":"Waldvogel-Abramowski","year":"2014","journal-title":"Transfus Med Hemother"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0070","doi-asserted-by":"crossref","first-page":"G397","DOI":"10.1152\/ajpgi.00348.2013","article-title":"Mechanistic and regulatory aspects of intestinal iron absorption","volume":"307","author":"Gulec","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1039\/b816714c","article-title":"A general map of iron metabolism and tissue-specific subnetworks","volume":"5","author":"Hower","year":"2009","journal-title":"Mol BioSyst"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbamcr.2015.01.021","article-title":"Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease","volume":"1853","author":"Lane","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0085","doi-asserted-by":"crossref","first-page":"G55","DOI":"10.1152\/ajpgi.90298.2008","article-title":"Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium","volume":"296","author":"Yeh","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5704","key":"10.1016\/j.metabol.2024.155953_bb0090","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0095","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.12.037","article-title":"Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation","volume":"140","author":"Brasse-Lagnel","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/liv.13513","article-title":"Hepatic iron is the major determinant of serum ferritin in NAFLD patients","volume":"38","author":"Ryan","year":"2018","journal-title":"Liver Int"},{"issue":"43","key":"10.1016\/j.metabol.2024.155953_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017613","article-title":"Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0110","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.27774","article-title":"Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis","volume":"62","author":"Hoki","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ajcn\/87.5.1374","article-title":"Pathways underlying iron accumulation in human nonalcoholic fatty liver disease","volume":"87","author":"Aigner","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2010.05.016","article-title":"Ferroportin disease: a systematic meta-analysis of clinical and molecular findings","volume":"53","author":"Mayr","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116855","article-title":"High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload","volume":"10","author":"Dongiovanni","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0130","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/liv.13124","article-title":"Hepcidin resistance in dysmetabolic iron overload","volume":"36","author":"Rametta","year":"2016","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.metabol.2024.155953_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbagen.2010.02.005","article-title":"Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage","volume":"1800","author":"Arosio","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim Biophys Acta"},{"issue":"32","key":"10.1016\/j.metabol.2024.155953_bb0145","doi-asserted-by":"crossref","first-page":"13089","DOI":"10.1073\/pnas.1105786108","article-title":"How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH","volume":"108","author":"Eckenroth","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","article-title":"SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis","volume":"22","author":"Jenkitkasemwong","year":"2015","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0155","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.26238","article-title":"Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease","volume":"57","author":"Maliken","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.24038","article-title":"Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease","volume":"53","author":"Nelson","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.15403\/jgld.2014.1121.243.hak","article-title":"The relationship of serum hemojuvelin and hepcidin levels with iron overload in nonalcoholic fatty liver disease","volume":"24","author":"Boga","year":"2015","journal-title":"J Gastrointestin Liver Dis"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0170","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0175","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications","volume":"57","author":"Kroot","year":"2011","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41416-022-01753-2","article-title":"Hepcidin in hepatocellular carcinoma","volume":"127","author":"Joachim","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2024.155953_bb0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-nutr-071813-105646","article-title":"Bone morphogenetic proteins as regulators of iron metabolism","volume":"34","author":"Parrow","year":"2014","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2006-07-033969","article-title":"STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation","volume":"109","author":"Falzacappa","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0195","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1007\/s12011-021-02610-8","article-title":"Nonalcoholic steatohepatitis modifies serum iron-related variables in patients with morbid obesity","volume":"199","author":"Hernandez-Aguilera","year":"2021","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0200","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0205","doi-asserted-by":"crossref","first-page":"G865","DOI":"10.1152\/ajpgi.00150.2011","article-title":"Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis","volume":"301","author":"Tan","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10.1016\/j.metabol.2024.155953_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0215","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.23712","article-title":"Hepatic iron loading in mice increases cholesterol biosynthesis","volume":"52","author":"Graham","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166142","article-title":"Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: role of iron-dependent pathways","volume":"1867","author":"Crawford","year":"2021","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1872-034X.2008.00464.x","article-title":"Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease","volume":"39","author":"Mitsuyoshi","year":"2009","journal-title":"Hepatol Res"},{"issue":"17","key":"10.1016\/j.metabol.2024.155953_bb0230","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3748\/wjg.15.2132","article-title":"Hyperferritinemia is a risk factor for steatosis in chronic liver disease","volume":"15","author":"Licata","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12072-018-9892-8","article-title":"Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population","volume":"13","author":"Jung","year":"2019","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187065","article-title":"Hepcidin in morbidly obese women with non-alcoholic fatty liver disease","volume":"12","author":"Auguet","year":"2017","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.metabol.2024.155953_bb0245","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.3390\/nu14245237","article-title":"Iron status and NAFLD among European populations: a bidirectional two-sample Mendelian randomization study","volume":"14","author":"Liu","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0250","first-page":"704","article-title":"Dietary iron and zinc intakes and nonalcoholic fatty liver disease: a meta-analysis","volume":"30","author":"Li","year":"2021","journal-title":"Asia Pac J Clin Nutr"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0255","doi-asserted-by":"crossref","first-page":"952","DOI":"10.5152\/tjg.2023.22453","article-title":"Serum ferritin and non-alcoholic fatty lliver disease: a meta-analysis and systematic review","volume":"34","author":"Yan","year":"2023","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0260","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with nonalcoholic fatty liver disease: a meta-analysis","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2024.155953_bb0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.20517\/2394-5079.2022.34","article-title":"Alteration in immune function in patients with fatty liver disease","volume":"8","author":"Gregory","year":"2022","journal-title":"Hepatoma Res"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(99)80032-4","article-title":"Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis","volume":"31","author":"Bonkovsky","year":"1999","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/nu10020175","article-title":"Dietary iron supplementation alters hepatic inflammation in a rat model of nonalcoholic steatohepatitis","volume":"10","author":"Atarashi","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0280","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/nu11092172","article-title":"A low iron diet protects from steatohepatitis in a mouse model","volume":"11","author":"Salaye","year":"2019","journal-title":"Nutrients"},{"issue":"34","key":"10.1016\/j.metabol.2024.155953_bb0285","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.3748\/wjg.v18.i34.4651","article-title":"Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis","volume":"18","author":"Ahmed","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0290","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jhep.2018.02.013","article-title":"The role of Kupffer cells in hepatic iron and lipid metabolism","volume":"69","author":"Scott","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0295","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/JLB.3A0318-108R","article-title":"Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis","volume":"105","author":"Handa","year":"2019","journal-title":"J Leukoc Biol"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0300","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jafc.1c06681","article-title":"Iron activates cGAS-STING signaling and promotes hepatic inflammation","volume":"70","author":"Li","year":"2022","journal-title":"J Agric Food Chem"},{"issue":"17\u201318","key":"10.1016\/j.metabol.2024.155953_bb0305","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.clinbiochem.2011.09.017","article-title":"Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis","volume":"44","author":"Uysal","year":"2011","journal-title":"Clin Biochem"},{"issue":"10308","key":"10.1016\/j.metabol.2024.155953_bb0310","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0315","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3748\/wjg.v25.i5.521","article-title":"Iron and liver fibrosis: mechanistic and clinical aspects","volume":"25","author":"Mehta","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0320","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/gast.1997.v112.pm9041250","article-title":"Hemosiderosis in cirrhosis: a study of 447 native livers","volume":"112","author":"Ludwig","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0330","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.1038\/s41598-021-89991-x","article-title":"Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjms.2017.08.012","article-title":"Iron enhances hepatic fibrogenesis and activates transforming growth factor-\u03b2 signaling in murine hepatic stellate cells","volume":"355","author":"Mehta","year":"2018","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0340","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/hep.30780","article-title":"Ablation of hepatocyte Smad1, Smad5, and Smad8 causes severe tissue iron loading and liver fibrosis in mice","volume":"70","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.metabol.2024.155953_bb0345","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3748\/wjg.v19.i19.2921","article-title":"Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2024.155953_bb0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.20517\/2394-5079.2021.136","article-title":"Hepatocellular carcinoma on the background of nonalcoholic fatty liver disease: epidemiological update","volume":"8","author":"Desjonqueres","year":"2022","journal-title":"Hepatoma Res"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1055-9965.EPI-13-0733","article-title":"Iron and cancer risk-a systematic review and meta-analysis of the epidemiological evidence","volume":"23","author":"Fonseca-Nunes","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0365","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1055-9965.EPI-21-0754","article-title":"Serum biomarkers of iron status and risk of hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease","volume":"31","author":"Yu","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0370","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3390\/cancers14092066","article-title":"Association between hepatic oxidative stress related factors and activation of Wnt\/\u03b2-catenin signaling in NAFLD-induced hepatocellular carcinoma","volume":"14","author":"Hamaguchi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0375","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2008.09.011","article-title":"Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis","volume":"50","author":"Sorrentino","year":"2009","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0380","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00535-007-2095-z","article-title":"Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C","volume":"42","author":"Kato","year":"2007","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0385","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.1875","article-title":"Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron","volume":"208","author":"Asare","year":"2006","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0390","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2353\/ajpath.2010.090249","article-title":"Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis","volume":"176","author":"Dongiovanni","year":"2010","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0395","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1101\/gad.299388.117","article-title":"Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2","volume":"31","author":"Zhang","year":"2017","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0400","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1084\/jem.20180900","article-title":"Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis","volume":"216","author":"Muto","year":"2019","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0405","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41418-019-0338-1","article-title":"Liver stage malaria infection is controlled by host regulators of lipid peroxidation","volume":"27","author":"Kain","year":"2020","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0410","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","article-title":"Ferroptosis in liver disease: new insights into disease mechanisms","volume":"7","author":"Wu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0415","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.apsb.2022.02.003","article-title":"Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease","volume":"12","author":"Tong","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.metabol.2024.155953_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174351","article-title":"Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4","volume":"908","author":"Zhu","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0425","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s11418-021-01491-4","article-title":"Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1\/Nrf2-ARE signaling pathway to reduce ferroptosis","volume":"75","author":"Gao","year":"2021","journal-title":"J Nat Med"},{"key":"10.1016\/j.metabol.2024.155953_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152599","article-title":"Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease","volume":"445","author":"Yang","year":"2020","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0435","first-page":"250","article-title":"TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination","volume":"35","author":"Zhang","year":"2022","journal-title":"Hum Cell"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0440","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","article-title":"Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice","volume":"190","author":"Qi","year":"2020","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0445","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1152\/ajpendo.00614.2020","article-title":"Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis","volume":"320","author":"Liu","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0450","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41420-022-01011-7","article-title":"Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0455","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41419-022-04764-2","article-title":"HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT\/GPX4 axis","volume":"13","author":"Tan","year":"2022","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0460","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/ijo.2023.5490","article-title":"High-throughput screening identification of a small-molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3\/GPX4 axis","volume":"62","author":"Huang","year":"2023","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12935-023-02946-2","article-title":"Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis","volume":"23","author":"Yan","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"8","key":"10.1016\/j.metabol.2024.155953_bb0470","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.metabol.2024.155953_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102349","article-title":"Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation","volume":"53","author":"Xu","year":"2022","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0480","article-title":"Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells","volume":"1868","author":"Liu","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0485","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20230128","article-title":"Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model","volume":"43","author":"Saha","year":"2023","journal-title":"Biosci Rep"},{"key":"10.1016\/j.metabol.2024.155953_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102963","article-title":"Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"2023","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0495","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41420-023-01477-z","article-title":"AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus","volume":"9","author":"Gong","year":"2023","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0500","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/liv.14945","article-title":"Inhibiting xCT\/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury","volume":"41","author":"Du","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2024.155953_bb0505","article-title":"TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0510","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif"},{"issue":"11","key":"10.1016\/j.metabol.2024.155953_bb0515","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1002\/ptr.7558","article-title":"Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1\/P53\/SLC7A11 pathway","volume":"36","author":"Liu","year":"2022","journal-title":"Phytother Res"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0520","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","article-title":"ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma","volume":"23","author":"Huang","year":"2021","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0525","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"21","key":"10.1016\/j.metabol.2024.155953_bb0530","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1111\/jcmm.16957","article-title":"Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11","volume":"25","author":"Fan","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0535","article-title":"Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2010.01.013","article-title":"Nrf2 the rescue: effects of the antioxidative\/electrophilic response on the liver","volume":"244","author":"Klaassen","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.metabol.2024.155953_bb0545","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodsona","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2024.155953_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102570","article-title":"Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease","volume":"59","author":"Liu","year":"2023","journal-title":"Redox Biol"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18321","article-title":"Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis","volume":"9","author":"Ye","year":"2023","journal-title":"Heliyon"},{"issue":"15","key":"10.1016\/j.metabol.2024.155953_bb0560","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.3390\/ijms241512510","article-title":"Icariin supplementation suppresses the markers of ferroptosis and attenuates the progression of nonalcoholic steatohepatitis in mice fed a methionine choline-deficient diet","volume":"24","author":"Choi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0565","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-related factor 2)","volume":"5","author":"Sharma","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155953_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102131","article-title":"Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis","volume":"46","author":"Wu","year":"2021","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0575","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155953_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101942","article-title":"Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation","volume":"41","author":"Sun","year":"2021","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0585","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10753-023-01823-4","article-title":"Camptothecin sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via suppression of Nrf2","volume":"46","author":"Elkateb","year":"2023","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0590","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.3390\/cells10123406","article-title":"Maresin-1 prevents liver fibrosis by targeting Nrf2 and NF-\u03baB, reducing oxidative stress and inflammation","volume":"10","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0595","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmgh.2021.01.007","article-title":"The ubiquitin E3 ligase TRIM21 promotes hepatocarcinogenesis by suppressing the p62-Keap1-Nrf2 antioxidant pathway","volume":"11","author":"Wang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155953_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102170","article-title":"The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress","volume":"47","author":"Wu","year":"2021","journal-title":"Redox Biol"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0605","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/antiox9090797","article-title":"Polyphenols by generating H2O2, affect cell redox signaling, inhibit PTPs and activate Nrf2 axis for adaptation and cell surviving: in vitro, in vivo and human health","volume":"9","author":"Kanner","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0610","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12944-023-01855-7","article-title":"Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis","volume":"22","author":"Yuan","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2024.155953_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153140","article-title":"Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2\/HO-1 antioxidant signaling pathway","volume":"67","author":"Qiu","year":"2020","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0620","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.metabol.2024.155953_bb0625","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopha.2018.06.060","article-title":"Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway","volume":"106","author":"Sui","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2024.155953_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155135","article-title":"Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis","volume":"122","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0635","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.gendis.2022.04.011","article-title":"All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis","volume":"9","author":"Sun","year":"2022","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0640","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","article-title":"Ferroptosis suppressor protein 1 inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer","volume":"16","author":"Cheu","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155953_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102546","article-title":"HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma","volume":"58","author":"Yuan","year":"2022","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0650","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000246","article-title":"Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma","volume":"7","author":"Liu","year":"2023","journal-title":"Hepatol Commun"},{"issue":"21","key":"10.1016\/j.metabol.2024.155953_bb0655","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin Med J"},{"issue":"Pt 1","key":"10.1016\/j.metabol.2024.155953_bb0660","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.freeradbiomed.2022.10.270","article-title":"The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin\u2013linked MAFLD","author":"Liu","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0665","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","article-title":"Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis","volume":"44","author":"Tong","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.metabol.2024.155953_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.109824","article-title":"Ferroptosis mediated by the interaction between Mfn2 and IRE\u03b1 promotes arsenic-induced nonalcoholic steatohepatitis","volume":"188","author":"Wei","year":"2020","journal-title":"Environ Res"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0675","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbalip.2015.01.008","article-title":"PPAR\u03b4 activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro","volume":"1851","author":"Kan","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0680","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0685","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/dna.2022.0582","article-title":"ZNF8-miR-552-5p axis modulates ACSL4-mediated ferroptosis in hepatocellular carcinoma","volume":"42","author":"Yang","year":"2023","journal-title":"DNA Cell Biol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0690","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0695","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108487","article-title":"HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications","volume":"33","author":"Zhao","year":"2020","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.metabol.2024.155953_bb0705","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-022-05137-5","article-title":"ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression","volume":"13","author":"Grube","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0710","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","article-title":"Puerarin ameliorates metabolic dysfunctionassociated fatty liver disease by inhibiting ferroptosis and inflammation","volume":"22","author":"Yang","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2024.155953_bb0715","doi-asserted-by":"crossref","first-page":"1148814","DOI":"10.3389\/fphar.2023.1148814","article-title":"Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis","volume":"14","author":"Ding","year":"2023","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0720","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.7150\/ijbs.85883","article-title":"Melatonin ameliorates hepatic ferroptosis in NAFLD by inhibiting ER stress via the MT2\/cAMP\/PKA\/IRE1 signaling pathway","volume":"19","author":"Guan","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0725","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","article-title":"Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis","volume":"29","author":"Guo","year":"2023","journal-title":"Mol Med"},{"key":"10.1016\/j.metabol.2024.155953_bb0730","article-title":"Imaging changes in the polarity of lipid droplets during NAFLD-induced ferroptosis via a red-emitting ffuorescent probe with a large stokes shift","volume":"231","author":"Zhao","year":"2023","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.metabol.2024.155953_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122230","article-title":"Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery","volume":"301","author":"Zhao","year":"2023","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0740","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0745","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molmed.2023.10.001","article-title":"Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes","volume":"30","author":"Pandeya","year":"2024","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0750","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.14428","article-title":"Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0755","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1325","article-title":"Mitochondrial general control of amino acid synthesis 5 like 1 promotes nonalcoholic steatohepatitis development through ferroptosis-induced formation of neutrophil extracellular traps","volume":"13","author":"Lv","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.metabol.2024.155953_bb0760","doi-asserted-by":"crossref","first-page":"1184280","DOI":"10.3389\/fendo.2023.1184280","article-title":"Identification of ferroptosis-related genes in the progress of NASH","volume":"14","author":"He","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0765","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.2019002907","article-title":"Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0770","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-0030-1255352","article-title":"Cell death and fibrogenesis","volume":"30","author":"Mehal","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.metabol.2024.155953_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166750","article-title":"Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway","volume":"1869","author":"Kitsugi","year":"2023","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.metabol.2024.155953_bb0780","article-title":"Integrated analysis and validation of TRIM23\/p53 signaling pathway in hepatic stellate cells ferroptosis and liver fibrosis","volume":"24","author":"Chen","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.metabol.2024.155953_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121591","article-title":"Supression Thioredoxin reductase 3 exacerbates the progression of liver cirrhosis via activation of ferroptosis pathway","volume":"321","author":"Liu","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2024.155953_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103029","article-title":"Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis","volume":"69","author":"Fu","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2024.155953_bb0795","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2023.02.012","article-title":"FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner","volume":"55","author":"Bi","year":"2023","journal-title":"J Adv Res"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0800","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.metabol.2024.155953_bb0805","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.metabol.2024.155953_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102151","article-title":"N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells","volume":"47","author":"Shen","year":"2021","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0815","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/iub.1895","article-title":"P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation","volume":"71","author":"Wang","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.metabol.2024.155953_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101619","article-title":"The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells","volume":"36","author":"Zhang","year":"2020","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0825","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.7150\/ijbs.66917","article-title":"Ferroptosis in cancer progression: role of noncoding RNAs","volume":"18","author":"Zuo","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"7\u20138","key":"10.1016\/j.metabol.2024.155953_bb0830","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1002\/jcp.29496","article-title":"MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells","volume":"235","author":"Bai","year":"2020","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.metabol.2024.155953_bb0835","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41419-022-05173-1","article-title":"LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.metabol.2024.155953_bb0840","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cbin.11444","article-title":"CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p\/GPX4 axis","volume":"44","author":"Xu","year":"2020","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.metabol.2024.155953_bb0845","doi-asserted-by":"crossref","first-page":"8929525","DOI":"10.1155\/2023\/8929525","article-title":"miR-21-5p inhibits ferroptosis in hepatocellular carcinoma cells by regulating the AKT\/mTOR signaling pathway through MELK","volume":"2023","author":"Hu","year":"2023","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0850","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12672-023-00761-9","article-title":"Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells","volume":"14","author":"Chen","year":"2023","journal-title":"Discov Oncol"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb0855","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1300","article-title":"Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation","volume":"13","author":"Shi","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.metabol.2024.155953_bb0860","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41420-020-00306-x","article-title":"Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.metabol.2024.155953_bb0865","doi-asserted-by":"crossref","first-page":"754","DOI":"10.21037\/jgo-21-916","article-title":"Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression","volume":"13","author":"Hu","year":"2022","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"10.1016\/j.metabol.2024.155953_bb0870","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","article-title":"Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a ceRNA","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.metabol.2024.155953_bb0875","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5582\/ddt.2023.01035","article-title":"LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p\/3p in hepatocellular carcinoma","volume":"17","author":"Zhou","year":"2023","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.metabol.2024.155953_bb0880","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221142818","article-title":"Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma","volume":"42","author":"Li","year":"2023","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0885","doi-asserted-by":"crossref","first-page":"2192438","DOI":"10.1080\/15592294.2023.2192438","article-title":"Suppressing circIDE\/miR-19b-3p\/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma","volume":"18","author":"Zhai","year":"2023","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0890","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41698-022-00283-7","article-title":"Blood-derived lncRNAs as biomarkers for cancer diagnosis: the good, the bad and the beauty","volume":"6","author":"Badowski","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.metabol.2024.155953_bb0895","article-title":"A novel ferroptosis-related long non-coding RNA prognostic signature correlates with genomic heterogeneity, immunosuppressive phenotype, and drug sensitivity in hepatocellular carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2024.155953_bb0900","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11627","article-title":"Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma","volume":"9","author":"Liang","year":"2021","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0905","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1038\/s41598-022-10508-1","article-title":"Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma","volume":"12","author":"Fang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2024.155953_bb0910","article-title":"Identification of a ferroptosis-related long noncoding RNA prognostic signature and its predictive ability to immunotherapy in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.metabol.2024.155953_bb0915","article-title":"Construction and validation of a ferroptosis-related lncRNA signature as a novel biomarker for prognosis, immunotherapy and targeted therapy in hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2024.155953_bb0920","article-title":"Construction of a ferroptosis-related nine-lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.metabol.2024.155953_bb0925","first-page":"6417","article-title":"Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors","volume":"34","author":"Lachaier","year":"2014","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb0930","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","article-title":"GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"19","key":"10.1016\/j.metabol.2024.155953_bb0935","doi-asserted-by":"crossref","first-page":"11092","DOI":"10.3390\/ijms231911092","article-title":"SHP-1\/STAT3-signaling-axis-regulated coupling between BECN1 and SLC7A11 contributes to sorafenib-induced ferroptosis in hepatocellular carcinoma","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.metabol.2024.155953_bb0940","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202000006","article-title":"Time course of changes in sorafenib-treated hepatocellular carcinoma cells suggests involvement of phospho-regulated signaling in ferroptosis induction","volume":"20","author":"Werth","year":"2020","journal-title":"Proteomics"},{"issue":"12","key":"10.1016\/j.metabol.2024.155953_bb0945","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.7150\/thno.82132","article-title":"Protein phosphatase 2A-B55\u03b2 mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenibinduced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling","volume":"13","author":"Qian","year":"2023","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.metabol.2024.155953_bb0950","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41401-022-00981-9","article-title":"Sorafenib triggers ferroptosis via inhibition of hepatitis B X-interacting protein (HBXIP)\/stearoyl-CoA desaturase (SCD) axis in hepatocellular carcinoma","volume":"44","author":"Zhang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0955","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-022-02296-3","article-title":"Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma","volume":"41","author":"Byun","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"22","key":"10.1016\/j.metabol.2024.155953_bb0960","doi-asserted-by":"crossref","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","article-title":"Long noncoding RNA URB1-antisense RNA 1 (AS1) suppresses sorafenib-induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0965","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2024.155953_bb0970","article-title":"FNDC5 causes resistance to sorafenib by activating the PI3K\/Akt\/Nrf2 pathway in hepatocellular carcinoma cells","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb0975","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","article-title":"Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis","volume":"42","author":"Li","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.metabol.2024.155953_bb0980","article-title":"CISD2 promotes resistance to sorafenib-induced ferroptosis by regulating autophagy in hepatocellular carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.metabol.2024.155953_bb0985","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2020.01.008","article-title":"Ferroptosis-driven nanotherapeutics for cancer treatment","volume":"319","author":"Shan","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.metabol.2024.155953_bb0990","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/IJN.S343361","article-title":"RNA-Seq explores the mechanism of oxygen-boosted sonodynamic therapy based on all-in-one nanobubbles to enhance ferroptosis for the treatment of HCC","volume":"17","author":"Chen","year":"2022","journal-title":"Int J Nanomedicine"},{"issue":"27","key":"10.1016\/j.metabol.2024.155953_bb0995","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301133","article-title":"Synergistic photochemo effects based on light-activatable dual prodrug nanoparticles for effective cancer therapy","volume":"12","author":"Liu","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb1000","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12951-022-01385-x","article-title":"Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization","volume":"20","author":"Chen","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.metabol.2024.155953_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113358","article-title":"Multifunctional Fe3O4-PEI@HA nanoparticles in the ferroptosis treatment of hepatocellular carcinoma through modulating reactive oxygen species","volume":"227","author":"Liang","year":"2023","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb1010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12951-021-01102-0","article-title":"Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis","volume":"19","author":"Zhou","year":"2021","journal-title":"J Nanobiotechnology"},{"issue":"5","key":"10.1016\/j.metabol.2024.155953_bb1015","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1021\/acsami.2c14962","article-title":"Arsenic-loaded biomimetic iron oxide nanoparticles for enhanced ferroptosis-inducing therapy of hepatocellular carcinoma","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.metabol.2024.155953_bb1020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.freeradbiomed.2017.09.002","article-title":"Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma","volume":"112","author":"Ou","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2024.155953_bb1025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jconrel.2022.08.050","article-title":"pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors","volume":"350","author":"Sun","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.metabol.2024.155953_bb1030","doi-asserted-by":"crossref","first-page":"1022330","DOI":"10.3389\/fbioe.2022.1022330","article-title":"A smart nanoplatform for enhanced photo-ferrotherapy of hepatocellular carcinoma","volume":"10","author":"Tang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.metabol.2024.155953_bb1035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40824-023-00401-x","article-title":"Fe3+-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma","volume":"27","author":"Xiao","year":"2023","journal-title":"Biomater Res"},{"key":"10.1016\/j.metabol.2024.155953_bb1040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2147\/IJN.S292528","article-title":"Co-administration of iRGD with sorafenib-loaded iron-based metal-organic framework as a targeted ferroptosis agent for liver cancer therapy","volume":"16","author":"Liu","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.metabol.2024.155953_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118782","article-title":"Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells","volume":"572","author":"Tang","year":"2019","journal-title":"Int J Pharm"},{"issue":"36","key":"10.1016\/j.metabol.2024.155953_bb1050","article-title":"Butyrate modification promotes intestinal absorption and hepatic cancer cells targeting of ferroptosis inducer loaded nanoparticle for enhanced hepatocellular carcinoma therapy","volume":"19","author":"Yu","year":"2023","journal-title":"Small"},{"issue":"19","key":"10.1016\/j.metabol.2024.155953_bb1055","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1021\/acs.jmedchem.2c00880","article-title":"A photoactivated sorafenib-ruthenium(II) prodrug for resistant hepatocellular carcinoma therapy through ferroptosis and purine metabolism disruption","volume":"65","author":"Lai","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2024.155953_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212761","article-title":"Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs","volume":"136","author":"Li","year":"2022","journal-title":"Biomater Adv"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb1065","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202663","article-title":"Amphiphilic dendrimer doping enhanced pH-sensitivity of liposomal vesicle for effective co-delivery toward synergistic ferroptosis-apoptosis therapy of hepatocellular carcinoma","volume":"12","author":"Su","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb1070","article-title":"Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma","volume":"18","author":"Luo","year":"2023","journal-title":"Asian J Pharm Sci"},{"issue":"43","key":"10.1016\/j.metabol.2024.155953_bb1075","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1021\/acs.analchem.2c03515","article-title":"Living cell-target responsive accessibility profiling reveals silibinin targeting ACSL4 for combating ferroptosis","volume":"94","author":"Yan","year":"2022","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.metabol.2024.155953_bb1080","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210518","article-title":"Ferroptosis in infection, inflammation, and immunity","volume":"218","author":"Chen","year":"2021","journal-title":"J Exp Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952400180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952400180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T15:11:04Z","timestamp":1720019464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952400180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":216,"alternative-id":["S002604952400180X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155953","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155953"}}